Breaking News Instant updates and real-time market news.

RETA

Reata Pharmaceuticals

$196.01

9.01 (4.82%)

13:28
11/14/19
11/14
13:28
11/14/19
13:28

Reata Pharmaceuticals price target raised to $305 from $210 at Stifel

Stifel analyst Adam Walsh raised his price target for Reata Pharmaceuticals to $305 from $210 and reiterates a Buy rating on the shares following the following positive Bardoxolone results in the pivotal Phase 3 Cardinal study in Alport syndrome. Both the primary and key secondary endpoints required for approval were achieved with statistical significance, and Bardoxolone is the first therapy to halt the progression of Alport chronic kidney disease, Walsh tells investors in a research note. The analyst raised his probability of success for the drug in Alport to 90% and believes these data read through favorably to other chronic kidney disease indications. He reiterates a Buy rating on Reata Pharmaceuticals.

  • 14

    Nov

RETA Reata Pharmaceuticals
$196.01

9.01 (4.82%)

11/04/19
CANT
11/04/19
NO CHANGE
Target $250
CANT
Overweight
Reata Pharmaceuticals price target raised to $250 from $180 at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan raised his price target for Reata Pharmaceuticals to $250 from $180 and keeps an Overweight rating on the shares. The analyst says results from his recent key opinion leader due diligence enhances his conviction in the clinical value for bardoxolone's Phase 3 Cardinal study in Alport syndrome.
11/12/19
SBSH
11/12/19
NO CHANGE
Target $328
SBSH
Buy
Reata Pharmaceuticals price target raised to $328 from $241 at Citi
Citi analyst Yigal Nochomovitz raised his price target for Reata Pharmaceuticals to $328 from $241 saying last night's Phase 3 bardoxolone data "hits it out of the park." The stock in premarket trading is down 8%, or $16.67, to $197.00. This data will be "more than sufficient" for Reata to obtain accelerated approval, Nochomovitz tells investors in a research note. He keeps a Buy rating on Reata Pharmaceuticals.
11/12/19
BARD
11/12/19
NO CHANGE
Target $245
BARD
Outperform
Reata Pharmaceuticals price target raised to $245 from $162 at Baird
Baird analyst Brian Skorney raised his price target on Reata Pharmaceuticals to $245 from $162 following the positive Phase 3 readout of its CARDINAL study. The report showed a clear on-treatment washout effect of barboxolone that was clinically meaningful and statistically superior to the placebo on eGFR in patients with Alport Syndrome. Skorney reiterated his Outperform rating on Reata Pharmaceuticals shares.
11/13/19
NATL
11/13/19
DOWNGRADE
NATL
Neutral
Reata Pharmaceuticals downgraded to Neutral from Buy at National Securities
National Securities analyst Maria Barbera downgraded Reata Pharmaceuticals to Neutral from Buy.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
12/05/19
12/05
12:17
12/05/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
12/05/19
12/05
12:16
12/05/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LUV

Southwest

$55.72

-0.05 (-0.09%)

12:15
12/05/19
12/05
12:15
12/05/19
12:15
Options
Southwest put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

  • 23

    Jan

SIGA

Siga Technologies

$4.39

-0.01 (-0.23%)

12:13
12/05/19
12/05
12:13
12/05/19
12:13
Hot Stocks
Siga announces CDND intent to purchase up to 15,325 courses of oral TPOXX »

SIGA Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPRT

Oportun Financial

$20.06

0.04 (0.20%)

12:11
12/05/19
12/05
12:11
12/05/19
12:11
Conference/Events
Oportun Financial management to meet with Jefferies »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

GALT

Galectin Therapeutics

$2.98

-0.06 (-1.97%)

12:09
12/05/19
12/05
12:09
12/05/19
12:09
Hot Stocks
Galectin Therapeutics plans adaptively designed Phase 3 NASH-RX trial »

Galectin Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$348.04

-0.85 (-0.24%)

12:09
12/05/19
12/05
12:09
12/05/19
12:09
Periodicals
Boeing to SEC: Doesn't see 737 MAX cancellations impacting revenue, Reuters says »

In a letter to the SEC,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MASI

Masimo

$156.34

-1.11 (-0.70%)

12:05
12/05/19
12/05
12:05
12/05/19
12:05
Conference/Events
Masimo management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ACHN

Achillion

$6.16

-0.025 (-0.40%)

12:05
12/05/19
12/05
12:05
12/05/19
12:05
Options
Achillion call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 19

    Dec

TVTY

Tivity Health

$22.60

-0.23 (-1.01%)

12:04
12/05/19
12/05
12:04
12/05/19
12:04
Conference/Events
Tivity Health management to meet with Piper Jaffray »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

MIC

Macquarie Infrastructure

$42.49

0.43 (1.02%)

12:04
12/05/19
12/05
12:04
12/05/19
12:04
Conference/Events
Macquarie Infrastructure management to meet with Suntrust »

Group Dinner with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

TCBK

TriCo Bancshares

$38.57

0.09 (0.23%)

12:03
12/05/19
12/05
12:03
12/05/19
12:03
Conference/Events
TriCo Bancshares management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 10

    Dec

  • 11

    Dec

  • 11

    Dec

FB

Facebook

$198.74

0.04 (0.02%)

, NKE

Nike

$94.84

1.12 (1.20%)

12:02
12/05/19
12/05
12:02
12/05/19
12:02
On The Fly
Fly Intel: Wall Street's top stories at midday »

After two volatile days…

FB

Facebook

$198.74

0.04 (0.02%)

NKE

Nike

$94.84

1.12 (1.20%)

AAPL

Apple

$263.99

2.21 (0.84%)

WORK

Slack Technologies

$22.30

0.61 (2.81%)

VRNT

Verint

$52.36

4.54 (9.49%)

AUPH

Aurinia Pharmaceuticals

$16.22

7.84 (93.56%)

SIG

Signet Jewelers

$18.21

1.56 (9.37%)

SPWH

Sportsman's Warehouse

$8.03

0.67 (9.10%)

SAGE

Sage Therapeutics

$63.20

-86.02 (-57.65%)

HOME

At Home Group

$5.61

-2.94 (-34.39%)

ESTC

Elastic

$65.45

-12.98 (-16.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 09

    Dec

  • 16

    Dec

  • 19

    Dec

PK

Park Hotels & Resorts

$23.53

-0.09 (-0.38%)

12:02
12/05/19
12/05
12:02
12/05/19
12:02
Conference/Events
Park Hotels & Resorts management to meet with Suntrust »

Hotel Property Tour with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

BRY

Berry Petroleum

$8.35

0.23 (2.83%)

12:02
12/05/19
12/05
12:02
12/05/19
12:02
Conference/Events
Berry Petroleum management to meet with Piper Jaffray »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

BAH

Booz Allen

$72.59

0.26 (0.36%)

, AMZN

Amazon.com

$1,745.65

-15.55 (-0.88%)

12:01
12/05/19
12/05
12:01
12/05/19
12:01
Hot Stocks
Booz Allen says has capabilities to support AWS Outposts »

Booz Allen Hamilton (BAH)…

BAH

Booz Allen

$72.59

0.26 (0.36%)

AMZN

Amazon.com

$1,745.65

-15.55 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOV

Hovnanian

$24.49

3.15 (14.76%)

12:00
12/05/19
12/05
12:00
12/05/19
12:00
Hot Stocks
Hovnanian rises 14.2% »

Hovnanian is up 14.2%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

AZZ

AZZ Inc.

$44.00

5.63 (14.67%)

12:00
12/05/19
12/05
12:00
12/05/19
12:00
Hot Stocks
AZZ Inc. rises 14.4% »

AZZ Inc. is up 14.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

EXPR

Express

$4.74

0.845 (21.72%)

12:00
12/05/19
12/05
12:00
12/05/19
12:00
Hot Stocks
Express rises 21.1% »

Express is up 21.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

CSIQ

Canadian Solar

$18.04

0.6 (3.44%)

, FSLR

First Solar

$53.47

-1.33 (-2.43%)

11:57
12/05/19
12/05
11:57
12/05/19
11:57
Periodicals
U.S. trade court grants injunction in solar tariff dispute, Bloomberg says »

The U.S. Court of…

CSIQ

Canadian Solar

$18.04

0.6 (3.44%)

FSLR

First Solar

$53.47

-1.33 (-2.43%)

JASO

JA Solar

$0.00

(0.00%)

SPWR

SunPower

$7.25

-0.12 (-1.63%)

TSL

Trina Solar

$0.00

(0.00%)

YGE

Yingli Green Energy

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$124.40

-0.02 (-0.02%)

11:57
12/05/19
12/05
11:57
12/05/19
11:57
Periodicals
Target to open Times Square store in NY in 2022, CNBC says »

Lauren Thomas of CNBC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$149.81

-0.04 (-0.03%)

11:55
12/05/19
12/05
11:55
12/05/19
11:55
Periodicals
Microsoft 365 consumer subscription to be revealed in spring 2020, ZDNet says »

Microsoft originally…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

11:55
12/05/19
12/05
11:55
12/05/19
11:55
General news
Treasury's $75 B 4- and 8-week bill auctions were very well received »

Treasury's $75 B 4-…

11:55
12/05/19
12/05
11:55
12/05/19
11:55
Conference/Events
William Blair aerospace & defense analyst to hold a group luncheon »

Aerospace & Defense…

11:55
12/05/19
12/05
11:55
12/05/19
11:55
Conference/Events
William Blair commercial services analyst to hold luncheon meeting »

Commercial Services…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.